Imaging to Assess Efficacy and Safety of New Treatments for Alzheimers Disease
Lead Participant:
IXICO TECHNOLOGIES LIMITED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| IXICO TECHNOLOGIES LIMITED | £977,825 | £ 269,079 |
Participant |
||
| UNIVERSITY COLLEGE LONDON | £466,970 | £ 466,970 |
People |
ORCID iD |